Opus Genetics (IRD) Cash From Operations

Annual CFO

-$1.11 M
-$15.43 M-107.77%

December 1, 2023


Summary


Performance

IRD Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRDcash flowmetrics:

Quarterly CFO

-$5.13 M
+$2.16 M+29.65%

September 1, 2024


Summary


Performance

IRD Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRDcash flowmetrics:

TTM CFO

-$13.59 M
-$2.13 M-18.56%

September 1, 2024


Summary


Performance

IRD TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRDcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IRD Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-107.8%+10.3%-327.1%
3 y3 years+83.6%+9.1%+29.8%
5 y5 years+69.0%+9.1%+29.8%

IRD Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-107.8%+94.3%-117.8%+29.6%-158.8%+32.5%
5 y5-year-107.8%+94.3%-117.8%+29.6%-158.8%+32.5%
alltimeall time-107.8%+94.3%-117.8%+29.6%-158.8%+32.5%

Opus Genetics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.13 M(-29.6%)
-$13.59 M(+18.6%)
Jun 2024
-
-$7.29 M(+27.6%)
-$11.46 M(+260.2%)
Mar 2024
-
-$5.72 M(-225.7%)
-$3.18 M(+186.2%)
Dec 2023
-$1.11 M(-107.8%)
$4.55 M(-251.4%)
-$1.11 M(-104.8%)
Sep 2023
-
-$3.00 M(-403.6%)
$23.13 M(+6.9%)
Jun 2023
-
$989.00 K(-127.1%)
$21.64 M(+28.5%)
Mar 2023
-
-$3.65 M(-112.7%)
$16.84 M(+17.6%)
Dec 2022
$14.31 M
$28.79 M(-740.1%)
$14.31 M(-171.1%)
Sep 2022
-
-$4.50 M(+18.1%)
-$20.12 M(+4.8%)
Jun 2022
-
-$3.81 M(-38.3%)
-$19.21 M(-2.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$6.17 M(+9.3%)
-$19.73 M(+1.8%)
Dec 2021
-$19.37 M(+185.0%)
-$5.65 M(+57.5%)
-$19.37 M(+7.1%)
Sep 2021
-
-$3.58 M(-17.2%)
-$18.08 M(+16.3%)
Jun 2021
-
-$4.33 M(-25.5%)
-$15.55 M(+31.0%)
Mar 2021
-
-$5.81 M(+33.4%)
-$11.88 M(+74.7%)
Dec 2020
-$6.80 M(+89.2%)
-$4.36 M(+312.7%)
-$6.80 M(+178.7%)
Sep 2020
-
-$1.06 M(+62.2%)
-$2.44 M(+76.4%)
Jun 2020
-
-$651.00 K(-11.1%)
-$1.38 M(+88.9%)
Mar 2020
-
-$732.00 K
-$732.00 K
Dec 2019
-$3.59 M
-
-

FAQ

  • What is Opus Genetics annual cash flow from operations?
  • What is the all time high annual CFO for Opus Genetics?
  • What is Opus Genetics annual CFO year-on-year change?
  • What is Opus Genetics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Opus Genetics?
  • What is Opus Genetics quarterly CFO year-on-year change?
  • What is Opus Genetics TTM cash flow from operations?
  • What is the all time high TTM CFO for Opus Genetics?
  • What is Opus Genetics TTM CFO year-on-year change?

What is Opus Genetics annual cash flow from operations?

The current annual CFO of IRD is -$1.11 M

What is the all time high annual CFO for Opus Genetics?

Opus Genetics all-time high annual cash flow from operations is $14.31 M

What is Opus Genetics annual CFO year-on-year change?

Over the past year, IRD annual cash flow from operations has changed by -$15.43 M (-107.77%)

What is Opus Genetics quarterly cash flow from operations?

The current quarterly CFO of IRD is -$5.13 M

What is the all time high quarterly CFO for Opus Genetics?

Opus Genetics all-time high quarterly cash flow from operations is $28.79 M

What is Opus Genetics quarterly CFO year-on-year change?

Over the past year, IRD quarterly cash flow from operations has changed by +$586.00 K (+10.25%)

What is Opus Genetics TTM cash flow from operations?

The current TTM CFO of IRD is -$13.59 M

What is the all time high TTM CFO for Opus Genetics?

Opus Genetics all-time high TTM cash flow from operations is $23.13 M

What is Opus Genetics TTM CFO year-on-year change?

Over the past year, IRD TTM cash flow from operations has changed by -$10.41 M (-327.09%)